Moreover, Guo and colleagues exhibited that Hepatocellular carcinoma progression is accelerated and prognosis is poor when RPLP2 is highly expressed because it inhibits ferroptosis (222). The gene discussed is RPLP2; the disease is hepatocellular carcinoma.